• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Malaria vaccine prevents one third of malaria cases at 12 months

  • in Public Health
  • — 20 Nov, 2012
John Lusingu
John Lusingu
Malaria vaccine prevents one third of malaria cases at 12 months
AudioMedica News
Malaria vaccine prevents one third of malaria cases at 12 months
Malaria vaccine prevents one third of malaria cases at 12 months
00:00 /
RSS Feed
Share
Link
Embed
//-->//>' class="input-embed input-embed-1992"/>
John Lusingu

John Lusingu

ATLANTA—Efficacy of the RTS,S malaria vaccine for children — vaccinated between six and 12 weeks age — checked-in at around 30 per cent in preliminary findings from Africa released at the American Society of Tropical Medicine and Hygiene conference by Dr John Lusingu of Tanzania’s National Institute of Medical Research. He told Sarah Maxwell that although this figure is lower than was hoped the data mean that a third of all cases of malaria are prevented among vaccinated children. Professor Sir Brian Greenwood of the London School of Hygiene & Tropical Medicine added his comment.



LISTEN

[audio:https://www.audiomedica.com/podcasting/global_health/121117JohnLusinguBrianGreenwoodPODCASTLoRes.mp3]

You may also like...

  • Malaria Elimination: Research Findings At ASTMH Conference Malaria Elimination: Research Findings At ASTMH Conference 2 Jan, 2012
  • 6 Months Exclusive Breast Feeding for Mothers with HIV Lowers Transmission Rates 6 Months Exclusive Breast Feeding for Mothers with HIV Lowers Transmission Rates 15 Mar, 2007
  • Latest on Human Papilloma Virus Vaccine for Cervical Cancer Latest on Human Papilloma Virus Vaccine for Cervical Cancer 7 Jan, 2006
  • Sabine Gabrysch Emergency Care For Childbirth Complications — Out Of Reach For Rural Women In Zambia? 20 Feb, 2011

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Previous story GAUSS STUDY: New alternative for LDL lowering in patients intolerant to statins
  • Next story Malaria: one baby in three protected 12 months after vaccination
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Ibrutinib: New Frontline Standard for Chronic…
    • Microbiome Diversity Key To Survival After…
    • Randomized Study Confirms Rivaroxaban Oral…
    • Pembrolizuab Monotherapy Extended Survival in…
    • Genomic-led AML Clinical Decision Making Within Seven Days
  • Home
  • Public Health
  • Malaria vaccine prevents one third of malaria cases at 12 months

© COPYRIGHT 2020 AUDIOMEDICA.COM.